Location History:
- Saint Bonnet de Mure, FR (2005)
- St. Bonnet de Mure, FR (2005 - 2008)
Company Filing History:
Years Active: 2005-2008
Title: Innovations by Jean-Jacques Pin
Introduction
Jean-Jacques Pin is a notable inventor based in St. Bonnet de Mure, France. He has made significant contributions to the field of cancer research, holding a total of 3 patents. His work focuses on methods that enhance the prognosis and diagnosis of cancer, which are crucial for improving patient outcomes.
Latest Patents
One of his latest patents involves methods for cancer prognosis and diagnosis. This invention provides techniques for detecting the infiltration of specific immune cells in human tumor tissues, which are associated with poor cancer prognosis. These methods are instrumental in making informed clinical decisions regarding cancer treatment, surveillance, and surgical intervention. Another significant patent pertains to polynucleotides encoding a mammalian Langerhans cell antigen. This includes purified mammalian dendritic cell surface protein, known as Langerin, along with nucleic acids encoding Langerin and antibodies that specifically bind to Langerin.
Career Highlights
Jean-Jacques Pin is affiliated with Schering Corporation, where he continues to advance his research and innovations in cancer diagnostics. His work has the potential to significantly impact clinical practices and improve patient care in oncology.
Collaborations
He has collaborated with esteemed colleagues such as Jean-Yves Guy, Christophe Blay, and Isabelle Andrée Lucette Treilleux, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Jean-Jacques Pin's contributions to cancer research through his patents and collaborations highlight his commitment to improving cancer prognosis and diagnosis. His work is paving the way for advancements in clinical decision-making and patient care.